Cargando…
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
In this study, the CRISPR/Cas9 technology was used to establish murine tumor cell lines, devoid of MHC I or MHC II surface expression, respectively. The melanoma cell line B16F10 and the murine breast cancer cell line EO-771, the latter stably expressing the tumor antigen NY-BR-1 (EO-NY), were trans...
Autores principales: | Das, Krishna, Eisel, David, Lenkl, Clarissa, Goyal, Ashish, Diederichs, Sven, Dickes, Elke, Osen, Wolfram, Eichmüller, Stefan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354463/ https://www.ncbi.nlm.nih.gov/pubmed/28301575 http://dx.doi.org/10.1371/journal.pone.0174077 |
Ejemplares similares
-
Correction: Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
por: Das, Krishna, et al.
Publicado: (2018) -
Cognate Interaction With CD4(+) T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype
por: Eisel, David, et al.
Publicado: (2019) -
Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line
por: Schröter, Philipp, et al.
Publicado: (2020) -
MicroRNAs affecting the susceptibility of melanoma cells to CD8(+) T cell‐mediated cytolysis
por: Pane, Antonino A., et al.
Publicado: (2023) -
Challenges of CRISPR/Cas9 applications for long non-coding RNA genes
por: Goyal, Ashish, et al.
Publicado: (2017)